Table 3.
Study | Population | Type of MMT when the test was done | Definition of hypoglycaemia | Prevalence of hypoglycaemia |
---|---|---|---|---|
Gasser, 2019 (42) | RYGB, n = 113, symptoms not stated | Carbohydrate rich MMT (201 kcal) Low-carbohydrate MMT (195 kcal) in PBH subset (n = 13) At 12 months post-op, 150 min |
<54 mg/dL (3.0 mmol/L) | 13.2% of RYGB with carbohydrate-rich MMT; none identified with PBH had hypo with low-carbohydrate MMT |
Roslin, 2014 (31) | RYGB, n = 12 VSG, n = 12 DS, n = 12 Symptoms not stated |
Mixed-meal in form of muffin containing 100 g glucose, post-op interval 9 months, 120 min | Not stated | Average 2 h glucose for RYGB= 85.3 ± 41 mg/dL (4.7 ± 2.3 mmol/L); VSG = 89.3 ± 39 mg/dL (5 ± 2.2 mmol/L); DS = 83.3 ± 23 mg/dL (4.6 ± 1.3 mmol/L) |
Faro, 2018 (43) | Symptomatic RYGB, n = 5 | MMT stimulus: 500 kcal, 20% protein, 20% fat and 60% carbohydrates), post-op interval 1.5–10 years, 120 min | Not stated | Nadir glucoses at 120 min of 45; 34; 52; 26; 43 mg/dL (respectively 2.5; 1.9; 2.9; 1.4; 2.4 mmol/L) |
Goldfine, 2007 (9) | Symptomatic RYGB, n = 12 Asymptomatic RYGB, n = 9 Non-RYGB similar BMI pre-op, n = 5 Non RYGB similar BMI post-op, n = 10 |
Ensure, 9 g protein, 40 g carbohydrates, 6 g fat, 240 mL, post-op interval 0.8–3.8 in symptomatic group, 2–4 years in asymptomatic group, 120 min | <60 mg/dL (<3.33 mmol/L) | 3/9 asymptomatic people developed asymptomatic hypoglycaemia |
Honka, 2019 (44) | Symptomatic RYGB, n = 43 Asymptomatic RYGB, n = 52 Separate cohort Symptomatic RYGB, n = 31 Asymptomatic RYGB, n = 18 |
350 kcal MTT (Ensure Plus®, 51 g carbohydrates) Isovolemic 250 kcal liquid MTT (Ensure®, 40 g carbohydrates) post-op interval not stated Sampling duration not stated |
Not stated | A nadir blood glucose cut-off of 53 mg/dL (2.9 mmol/L) produced the highest sum of sensitivity (65%) and specificity (88%) for detecting hypoglycaemia |
Jacobsen, 2012 (45) | Eight people pre and 2 weeks after RYGB | 200 mL liquid mixed meal test (Nutridrink, Nutricia, Netherlands) containing 300 kcal (1260 kJ) with 49% carbohydrate, 35% fat and 16% protein. Also compared to 25 and 50 g OGTT, 210 min | Not stated | No change pre- and post-operatively |
Kefurt, 2015 (46) | Symptoms not stated, RYGB, n = 51 | 200 mL liquid (all in® COMPLETE Kaffee, Allin, Vienna) containing 7.2 g fat, 28.4 g carbohydrates and 16 g protein, post-op interval mean 7.2 years, 180 min | <55 mg/dL (3.1 mmol/L) | 29% |
Lee, 2022 (47) | Symptomatic SG, n = 12 Asymptomatic SG, n = 11 Symptomatic RYGB, n = 7 Asymptomatic RYGB, n = 13 |
8-ounce Ensure Plus drink (Abbott Laboratories; 350 kcal, 50 g carbohydrates, 13 g protein, and 11 g fat), post-op interval average 5 years, 240 min | <60 mg/dL (3.3 mmol/L) | SG 39%, RYGB 40% |
Lobato, 2020 (12) | Symptomatic RYGB, n = 14 Asymptomatic RYGB, n = 9 |
Liquid Mixed Meal (Fresubin Energy Drink, 200 mL, 300 kcal (50E% carbohydrate, 15E% protein and 35E% fat); Fresenius Kabi Deutschland, Bad Homburg, Germany), post-op interval ~3–5 years, 120 min | <55 mg/dL (3.1 mmol/L) | 50% symptomatic, 44.4% asymptomatic |
Mulla, 2019 (15) | Symptomatic RYGB, n = 11 Asymptomatic RYGB, n = 7 Overweight non operated, n = 3 Obesity non operated, n = 4 |
(Ensure, 40 g carbohydrates, 9 g protein, 6 g fat, 240 mL; Abbott Laboratories, Abbott Park, IL) Post-op interval not stated, 120 min |
Not defined | Nadir glucose (mmol/L) (RYGB symptomatic: 4.3 ± 0.2; RYGB asymptomatic: 3.9 ± 0.1; Overweight non operated: 5.5 ± 0.2; Obesity non operated: 5.3 ± 0.3 |
Patti, 2015 (48) | Symptomatic RYGB, n = 17 Asymptomatic RYGB, n = 6 |
(Ensure, 40 g carbohydrates, 9 g protein, 6 g fat, 240 mL) post-op interval ~3–5 years, 120 min | <60 mg/dL (3.33 mmol/L) | Hypos detected in 7/17 (41%) of the symptomatic group 0/9 of the asymptomatic group had hypos |
Preskill, 2015 (49) | Symptomatic RYGB, n = 31 Asymptomatic RYGB, n = not reported |
MMT containing carbohydrate, fat, and protein (in solid form), post-op interval not reported, 300 min | <55 mg/dL (<3.1 mmol/L) | 2/31 of the symptomatic group Asymptomatic not reported |
Raverdy, 2017 (50) | RYGB, n = 89 AGB, n = 20 Unselected prospective cohort study |
MMT not specified, pre-surgery, 12 and 60 months post surgery, 180 min | Not specified | 2 h post-prandial lower after RYGB than AGB |
Salehi, 2010 (51) | Symptomatic RYGB, n = 20 with CBG <50 mg/dL Asymptomatic RYGB, n = 21 |
MMT 350 kcal not specified, post-op interval and sampling duration not reported | Not specified | Nadir glucose <50 mg/dL (<2.8 mmol/L) in 9/20 symptomatic and 5/21 asymptomatic |
Smajis, 2016 (52) | Symptomatic RYGB (GB), n = 10 Symptomatic of hypoglycaemia but with no surgery (CON), n = 5 |
Solid MMT (one meal consisting of 40 g whole wheat bread, 15 g butter, 20 g honey and 100 g banana (total kcal: 360; 4 g protein, 13 g fat, 57 g carbohydrate), post-op interval not reported, 240 min | <55 mg/dL (3.1 mmol/L) | Asymptomatic hypoglycaemia detected in GB = 2/10 and CON = 2/5 |
Emous, 2019 (53) | RYGB, n = 44 | 200 mL liquid nutrition supplement (Abbott Ensure S Plus) containing 300 kcal, 12.5 g protein, 40.4 g carbohydrate (of which 13.8 g is sugars), 9.84 g fat and 154.9 g water MMT, 4 years post-op, 210 min | <60 mg/dL (3.3 mmol/L) | Hypos in 48%, all asymptomatic |
Tharakan, 2017 (54) | Symptomatic RYGB, n = 18 Asymptomatic RYGB, n = 10 non-RYGB controls, n = 9 |
Ensure Plus food supplement (13.8 g of protein, 10.8 g of fat, 44.4 g of carbohydrates, 330 kcal, 220 mL, Abbott) | <3.0 mmol/Ll | Hypos in 7/18 symptomatic people |
Johannson, 2010 (55) | BPD-DS, n = 10 Normal weight controls, n = 12 |
Mixed meal including hamburger, and jam sandwich with margarine and oat bread, 2400 kJ (570 kcal), consisting of: carbohydrates 68.2 g, fat 22.3 g, proteins 24.6 g and fibre 6.4 g. 2 years post-op, 180 min |
Not prespecified | No reported hypoglycaemia |
BPD-DS, biliopancreatic diversion with duodenal switch; DS, duodenal switch; (L)AGB, (laparoscopic) adjustable gastric banding; MMT, mixed meal test; RYGB, Roux-en-Y gastric bypass; SG, sleeve gastrectomy; VSG, vertical sleeve gastrectomy.